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Huntington’s disease (HD) is an inherited neurodegenerative disorder in which the
striatum is the most affected brain region. Although a chronic inflammatory microglial
reaction that amplifies disease progression has been described in HD patients, some
murine models develop symptoms without inflammatory microglial activation. Thus,
dysfunction of non-inflammatory microglial activity could also contribute to the early
HD pathological process. Here, we show the involvement of microglia and particularly
fractalkine signaling in the striatal synaptic dysfunction of R6/1 mice. We found reduced
fractalkine gene expression and protein concentration in R6/1 striata from 8 to 20 weeks
of age. Consistently, we also observed a down-regulation of fractalkine levels in the
putamen of HD patients and in HD patient hiPSC-derived neurons. Automated cell
morphology analysis showed a non-inflammatory ramified microglia in the striatum of
R6/1 mice. However, we found increased PSD-95-positive puncta inside microglia,
indicative of synaptic pruning, before HD motor symptoms start to manifest. Indeed,
microglia appeared to be essential for striatal synaptic function, as the inhibition of
microglial activity with minocycline impaired the induction of corticostriatal long-term
depression (LTD) in wild-type mice. Notably, fractalkine administration restored impaired
corticostriatal LTD in R6/1 mice. Our results unveil a role for fractalkine-dependent
neuron-microglia interactions in the early striatal synaptic dysfunction characteristic
of HD.
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INTRODUCTION
Huntington’s disease (HD) is an inherited neurodegenerative disorder characterized by motor,
cognitive, and psychiatric disturbances. It is caused by a CAG repeat expansion in the huntingtin
gene, leading to abnormal toxic aggregates of mutant huntingtin (mHtt). Neuropathology of HD is
prominent in the striatum, the main primary input of basal ganglia (Morigaki and Goto, 2017) and
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the cerebral cortex, which extensively projects glutamatergic
afferents to medium spiny neurons (MSNs) in the striatum.
HD disrupts the mechanisms by which cortical and MSNs
communicate before the onset of symptoms (Unschuld et al.,
2012; Burgold et al., 2019), making corticostriatal pathway
dysfunction a keystone in the pathophysiology of the disease
(Miller et al., 2011; Wilkes et al., 2019). Some data from
HD mouse models suggest that deficits in synaptic plasticity
and neuronal processing are the cellular basis for this specific
neurodegeneration. For example, loss of corticostriatal synapses
(Deng et al., 2013), altered striatal long-term depression (LTD)
(Cummings et al., 2007; Creus-Muncunill et al., 2019; Ghiglieri
et al., 2019) and reduction of striatal excitatory postsynaptic
currents (Cepeda et al., 2003) have been described in R6/1
mice, a transgenic model of HD. This progressive corticostriatal
communication impairment markedly alters basal ganglia
circuitry activity, ultimately leading to motor disturbances (Hong
et al., 2012; Puigdellívol et al., 2015; Veldman and Yang, 2018).
Microglia, the resident immune cells of the CNS, are
activated in the brain of HD patients years before clinical
manifestations appear (Tai et al., 2007). Evidence suggests
that early microglial activation is triggered by mHtt-mediated
excitotoxicity and is one of the mechanisms mediating HD
pathogenesis (Tai et al., 2007; Yang et al., 2017). However,
the nature of such activation remains elusive and whether it
presents beneficial or detrimental consequences in HD is still a
matter of study. On the one hand, microglia in the striatum of
patients and some HD models proliferate and present a classical
inflammatory morphological phenotype (Sapp et al., 2001).
These cells release neurotoxic pro-inflammatory cytokines, which
results in microglial over-activation that finally aggravate HD
progression (Crotti et al., 2014). On the other hand, activated
microglia also produce anti-inflammatory cytokines and growth
factors with trophic and neuroprotective functions (Yang et al.,
2017). In HD, these contradictory functions of microglia can
be found simultaneously. Thus, transforming growth factor
beta (TGF-β) and vascular endothelial growth factor (VEGF),
two characteristic biomarkers of alternative non-inflammatory
microglial activation (Liu et al., 2013; Yang et al., 2017), have
been reported to co-exist with pro-inflammatory cytokines in
HD plasma and post-mortem brain tissue (Battaglia et al., 2011;
Di Pardo et al., 2013; Chang et al., 2015). Additionally, HD
microglial cells express high levels of mHtt (Ferrante et al.,
1997) which induces cell-autonomous microglial pathogenic
mechanisms (Crotti et al., 2014; Creus-Muncunill and Ehrlich,
2019; Siew et al., 2019). For example, mHtt impairs microglial
motility in response to ATP in HD mice (Kwan et al., 2012) an
impairment also observed in CX3CR1-KO mice (Pagani et al.,
2015). This cellular dysfunction introduces a new element of
complexity to the unclear role of microglia in HD.
In the healthy brain, microglia are continuously and actively
scanning the brain environment, moving their processes and
sensing neuronal activity without perturbing neuronal networks.
Surveillant microglia phagocytose inactive synapses (Wake et al.,
2009; Schafer et al., 2012) via expression of traditional immune
complement molecules (Wake et al., 2013; Hong et al., 2016), and
promote synapse and/or spine formation during development
and after injury (Parkhurst et al., 2013; Miyamoto et al., 2016) and
sensory experience (Tremblay et al., 2010) contributing to sculpt
neuronal circuits.
In physiological conditions neurons specifically release
fractalkine (FKN) to maintain the surveillant state of microglia
(Ransohoff and Perry, 2009). FKN, also known as CX3CL1,
is expressed as a membrane-bound glycoprotein that is
proteolytically cleaved to release a soluble chemokine (Harrison
et al., 1998). FKN modulates microglial motility, migration and
activation by interaction with CX3CR1, its only specific receptor
that in the brain parenchyma is restricted to microglia (Cardona
et al., 2006; Chiu et al., 2013). The FKN-CX3CR1 axis not only
contributes to maintaining the surveillant state of microglia but
also has a role in modulating synaptic plasticity and neuronal
survival (Rogers et al., 2011; Lauro et al., 2015; Luo et al.,
2019). In the hippocampus, FKN-CX3CR1 interactions prevent
glutamate-mediated excitotoxicity and apoptosis (Deiva et al.,
2004) modulate glutamatergic synapses (Ragozzino et al., 2006;
Paxinos and Franklin, 2012), and promote adenosine release by
microglia (Lauro et al., 2010). Under pathological conditions
FKN has conflicting effects on microglia, being neuroprotective
and anti-inflammatory in some contexts, while pro-inflammatory
and neurotoxic in others (Lauro et al., 2015). Therefore,
abnormalities in the FKN-CX3CR1 axis may lead to dysfunction
of non-inflammatory microglial activity and contribute to the
pathological processes described in HD.
We hypothesized that changes in FKN-CX3CR1 interactions
contribute to the striatal synaptic plasticity dysfunction
characteristic of HD from early stages of the disease. To
validate our hypothesis we used post-mortem striatal samples
of HD patients, human induced pluripotent stem cells (hiPSC)
derived striatal neurons, and R6/1 mice. This HD mouse
model is extensively characterized, exhibiting an onset of motor
symptoms from 14 to 15 weeks of age and a progressively severe
disease phenotype (Mangiarini et al., 1996; Puigdellívol et al.,
2015). Our results unveil a role for FKN-dependent neuron-




Male and female R6/1 transgenic mice expressing the human
exon-1 of mHtt containing 115 CAG repeats and their
corresponding wild-type (WT) littermates were obtained from
Jackson Laboratory (Bar Harbor, ME, United States) and
maintained in a B6CBA background. Polymerase chain reaction
(PCR) from tail biopsy samples was used to determine genotypes.
Animals were housed together in groups of mixed genotypes and
kept under a 12:12 h light/dark cycle in a room at 19–22◦C and
40–60% humidity, with free access to food and water. Mouse
identification and data analysis were recorded by microchip
mouse number. All animal procedures were approved by the
animal experimentation Ethics Committee of the University of
Barcelona in accordance with the regulations established by
the Catalan government, the Spanish regulation (RD 53/2013)
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and European guidelines (2010/63/UE for the care and use of
laboratory animals.
Human Post-mortem Nervous Tissue
Human post-mortem tissue samples of putamen were used to
assess FKN expression and concentration. These samples were
obtained from the Neurological Tissue Bank of the Biobanc-
Hospital Clínic-Institut d’Investigacions Biomèdiques August Pi
i Sunyer (IDIBAPS, Barcelona, Spain1), following the guidelines
and approval of the Ethics Committee of the University of
Barcelona and the European ethical guidelines. Samples were
collected at autopsy from individuals who had suffered a clinical
history of HD (n = 8, age: 62.5 ± 7.2 years; postmortem
intervals of 4–18 h), and from non-HD controls (n = 12, age:
54.5 ± 6.5 years; postmortem intervals of 4–17 h). Samples were
fresh-frozen and stored at −80◦C for quantitative real-time PCR
(qRT-PCR) and western blot analysis.
Human iPSC Culture, Differentiation and
Immunostaining
Two human iPSC lines were employed in this study. Firstly, the
CS83iCTR-33nXX (CTR33) line was used, which was derived
from an unaffected sibling of a HD patient with genotyped CAG
repeat length of 33 in the HTT gene. This line was reprogrammed
using a non-integrating strategy and was developed as a “control”
line for a related study on HD hiPSC characterization (Telezhkin
et al., 2018). Secondly, the CS21iHD60n5 (HD60) line was used
(Hd iPSC Consortium, 2017) which was derived from an HD
juvenile patient and re-programmed using integrating vectors.
HiPSC lines were cultured and differentiated as previously
described (Comella-Bolla et al., 2020). In brief, cells were kept in
the pluripotent state using mTeSRTM1 (Stem Cell Technologies,
Grenoble, France) on BD Matrigel-coated plates (BD Biosciences,
Oxford, Oxon, United Kingdom), and differentiated to neural
progenitors using an in-house differentiation protocol as
described elsewhere (Comella-Bolla et al., 2020).
Immunocytochemistry
HiPSC-derived cultures at DIV 37 were fixed at room
temperature with 4% (w/v) paraformaldehyde (Fisher Scientific
UK Limited, Leicestershire, United Kingdom), washed in
PBS and stored at 4◦C in 0.03% Sodium-Azide (Sigma-
Aldrich, Madrid, Spain) PBS until use. For immunolabeling,
samples were blocked and permeabilized for 45 min with PTB
solution [PBS with 0.3% Triton X-100 (Sigma-Aldrich), 0.03%
Sodium-Azide, 1% BSA (Sigma-Aldrich) and/or 5% Normal
Goat serum (Vector Laboratories Ltd., United Kingdom) and
5% Donkey Serum (Jackson Immuno Research Laboratories
Inc.; PA, United States)], before being incubated overnight
at 4◦C with primary antibodies (Table 1). After overnight
incubation, samples were washed with PBS. Then cells were
incubated for 90 min at room temperature in darkness
in smooth motion with appropriated fluorophore-conjugated
secondary antibodies (Table 1). After washing in PBS, cells
1www.clinicbiobanc.org
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1:1000
Polyclonal rabbit anti-Iba1 Wako Chemicals, United States 1:800





AF555 goat anti-mouse IgG
(H+L)
Thermo Fisher Scientific,
Waltham, MA, United States
1:500
Western blot procedure
Polyclonal goat anti-fractalkine R&D systems, United States 1:500
Polyclonal rabbit anti-β-actin Santa Cruz Biotechnology,
United States
1:20,000
HRP donkey anti-goat IgG Promega, United States 1:2000
HRP donkey anti-rabbit IgG Promega, United States 1:5000
were counterstained with DAPI (4′,6-diamidino-2-phenylindole)
for nuclear staining (Thermo Fisher Scientific, Waltham, MA,
United States). Coverslips were mounted in Fluoromount-
G media (Southern Biotech, AL, United States) and imaged
using a Leica SP5 TCS Two-photon laser scanning confocal
microscope (Leica Microsystems Heidelberg GmbH, Mannheim,
Germany). FKN staining was quantified using the open-access
CellProfiler software (BROAD institute, MA, United States).
Three independent experiments were run in parallel for each cell
line, CTR33 and HD60, from which we analyzed two replicas.
Three to five pictures of fields of view were taken with the
epifluorescence Leica AF600 microscope (Leica Microsystems,
Wetzlar, Germany). For each picture we analyzed (1) the total
area covered by MAP2B staining to assess the neuronal density
and (2) the mean intensity of FKN staining.
Quantitative Real-Time PCR
Aqueous phase containing total RNA was isolated from human
and mouse brain regions or cells using TRI Reagent (Sigma-
Aldrich) following the manufacturer’s protocol. Then total
RNA was purified with Direct-zol RNA MiniPrep Plus (Zymo
Research, Irvine, CA, United States). A range of 0.25 to 1 µg
of RNA for each condition was reverse transcribed using a
PrimeScript RT reagent kit (Takara, Japan). The RT reaction
was performed at 42◦C for 60 min followed by an additional
5 min at 70◦C. cDNA was diluted to 5 ng/µL and 2 µL was
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 June 2020 | Volume 14 | Article 163
fncel-14-00163 June 16, 2020 Time: 18:56 # 4
Kim et al. Fractalkine and Synaptic Plasticity in HD
TABLE 2 | PrimeTime qPCR assays used in the study.
Gene Assay code RefSeq number Species
Fractalkine Hs.PT.56a.1173656 NM_002996 Homo sapiens
CX3CR1 Hs.PT.58.4589254 NM_001171174 Homo sapiens
GAPDH Hs.PT.56a.40035104 NM_002046 Homo sapiens
Rn18s Hs.PT.39a.22214856.g NR_003286 Homo sapiens
RPL13A Hs.PT.51.21531404 NM_012423 Homo sapiens
Fractalkine Mm.PT.56a.8767901 NM_009142 Mus musculus
Cx3cr1 Mm.PT.56a.17555544 NM_009987 Mus musculus
Gapdh Mm.PT.39a.1 NM_008084 Mus musculus
Rn18s Control 18s NR_003286 Mus musculus
Pcna Mm.PT.56a.23375948 NM_011045 Mus musculus
C1qb Mm.PT.58.7170292 NM_009777 Mus musculus
C3 Mm.PT.58.17325540 NM_009778 Mus musculus
Ptger4 Mn.PT.58.10399658 NM_008965 Mus musculus
Smad2 Mn.PT.58.12362708 NM_010754 Mus musculus
Smad3 Mn.PT.58.10139890 NM_016769 Mus musculus
Tgbr1 Mn.PT.5828402453 NM_009370 Mus musculus
Tyrbp Mn.PT.58.6069426 NM_011662 Mus musculus
used to perform qRT-PCR. PrimeTime qPCR assays (Table 2)
were used as recommended by provider (IDT technologies,
United States). qRT-PCR was carried out with Premix Ex Taq
(RR390A, Takara, Japan) in 6 µL final volume using a CFX384-
C1000 thermal cycler (Bio-Rad Laboratories, Madrid, Spain).
The two-step amplification program was: 40 cycles of 2 min at
95◦C for denaturation and polymerase activation, 5 s at 95◦C
for denaturation, and a final extension for 20 s at 60◦C. For
each target gene, the expression level was determined using a
standard curve (efficiency between 93 and 100%) and normalized
to housekeeper gene mRNA levels. Reactions were performed in
triplicate to reduce variability. The 11Ct method was used to
analyze the data.
Western Blot Analysis
Total protein extracts were obtained after organic separation
and homogenization of samples in TRI Reagent (Sigma-Aldrich)
following the manufacturer’s instructions. Protein concentration
was determined by the Bradford assay (Bio-Rad Laboratories).
Western blot analyses were performed as described previously
(Comella-Bolla et al., 2019). In brief, 20 µg of total protein
extracts were subjected to 10% SDS-PAGE, then proteins
were transferred to Nitrocellulose membrane (Amersham
Pharmacia Biotech, San Francisco, CA, United States) and
probed by incubation with either anti-β-actin or anti-FKN
primary antibodies, washed and incubated with appropriate
secondary antibodies (Table 1). Chemiluminescent detection
was performed by incubating with Luminata Classico Western
HRP Substrate (Millipore, Burlington, MA, United States) and
exposure to Fuji Medical X-Ray Film Super RX-N (Fujifilm,
Japan). Western blot quantification was performed on digital
acquired films by using ImageJ Gel Analysis. Data were expressed
as the ratio between the band intensity of the protein of
interest and that of β-actin. The relative ratio between FKN
immunoreactive bands was also calculated.
Immunohistochemistry and Image
Analysis
Wild-type and R6/1 mice were sacrificed via cervical dislocation.
Brains were isolated and post-fixed overnight with 4%
paraformaldehyde, cryoprotected with 30% (w/v) sucrose
in PBS, frozen in dry ice and stored at −80◦C until sectioning.
Serial 40 µm sections were obtained at level 2.4 mm anterior to
Bregma on the cryostat, and stored in 0.02% Sodium-Azide (w/v)
in PBS at 4◦C until use. To label post-synaptic glutamatergic
spines and microglial cells, double immunohistochemistry
was performed with anti-PSD-95 and anti-Iba1 antibodies,
respectively, as previously described (Espinosa-Parrilla et al.,
2015). Briefly, sections were first washed in PBS containing
0.3% (v/v) Triton X-100. They were then incubated with 50 mM
NH4Cl in PBS for 15 min. After a new washing with 0.3% Triton-
X100 PBS, sections were incubated with a blocking solution
of PBS containing 0.3% Triton-X100 and 10% Normal Goat
Serum for 2 h. Sections were then co-incubated overnight at 4◦C
with both anti-Iba1 and anti-PSD-95 antibodies (Table 1). After
washing in the blocking solution, sections were then incubated
for 2 h with combinations of appropriate secondary antibodies
(Table 1). All antibodies were diluted in the previously described
blocking solution. Incubations with either mouse or rabbit IgG
as primary antibodies were used for negative controls. All washes
and incubations were done at room temperature, except for
the primary antibody incubation, which was done at 4◦C. After
antibody incubations, slices were washed, incubated in DAPI,
mounted with Fluoromount-G and kept in the dark.
Stereological counting of microglial cells was preformed
on Iba-1 single immunostained sections. Striatal regions were
outlined at 2.5× magnification on arbitrary uniform random
(AUR) coronal sections. Individual cells were viewed at
40× and then counted. We applied the FIJI Auto Local
Threshold plugin followed by the Analyze Particles Plugin
for ImageJ to identify and analyze cells. For the microglial
morphological analysis, series of confocal images from Iba-1-
immunostained sections were acquired at 63× (oil immersion,
1.5 µm step size and a zoom of 1×) using a Leica
SP5 Two-photon confocal microscope. Microglial morphology
was semi-automatically processed in 3D using 3DMorph, a
MATLAB-based program developed by York et al. (2018).
For image acquisition and processing the voxel sizes were
0.241 µm in the XY plane with a 1.5 µm step size. Only
the 488 nm channel (labeling the Iba-1 stained cells) was
used for picture acquisition, and all cell processes (small
and large) were used in our analysis. The microglial cell
parameters analyzed were: cell volume, territorial volume, cell
complexity (estimated as the quotient cell territory/cell volume),
the number and longitude of cell processes and the number
of endpoints. For every image acquired, 7–10 full cells were
isolated and analyzed. To determine the relative amount of
PSD-95-immunopositive puncta inside of Iba1-positive cells,
confocal images were acquired at 63×, a 130 nm step size
and a zoom of 3.5×. Then, images were processed with
Imaris (Oxford Instruments, United Kingdom) to create a 3D
reconstruction of microglia and count the post-synaptic puncta
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inside them (Supplementary Video). The images were prepared
and rendered, and the relative amount of PSD-95 positive puncta
engulfed by microglia was calculated using the engulfment assay
described by Schafer et al. (2014).
Electrophysiological Field Recordings
Wild-type and R6/1 mice were sacrified via cervical dislocation.
Brains were quickly removed and immersed on oxygenated (95%
O2, 5% CO2) ice-cold aCSF containing (in mM) 124 NaCl,
24 NaHCO3, 13 glucose, 5 HEPES, 2.5 KCl, 2.5 CaCl2, 1.2
NaH2PO4 and 1.3 MgSO4. Mouse brain sagittal sections were
obtained on a vibratome (Microm HM 650 V, Thermo Fisher
Scientific, Waltham, MA, United States) at 350 µm thickness
in oxygenated ice-cold aCSF. Slices were then transferred to an
oxygenated 32◦C recovery solution of the following composition
(in mM): 92 NMDG, 30 NaHCO3, 25 glucose, 20 HEPES,
10 MgSO4, 5 sodium ascorbate, 2.5 KCl, 1.2 NaH2PO4, 3
sodium pyruvate, 2 thiourea, and 0.5 CaCl2; at 32◦C for
15 min (Choi et al., 2019). Then, slices were transferred to
oxygenated aCSF at room temperature and left for at least 1 h
before recording.
For recording, slices were placed in a multi electrode array
(MEA) recording dish and fully submerged in oxygenated aCSF
at 34◦C. Electrophysiological data were recorded with a MEA
set-up from Multi Channel Systems MCS GmbH (Reutlingen,
Germany) composed of a 60 channels USB-MEA60-inv system
with a blanking unit from Multi Channel Systems and a STG4004
current and voltage generator. Experiments were carried out
with 60MEA200/30iR-ITO MEA dishes consisting of 60 planar
electrodes (30 µm diameter) arranged in an 8 × 8 array
(200 µm distance between neighboring electrodes). Software for
stimulation, recording and signal processing were MC Stimulus
and MC Rack from Multi Channel Systems. Using a digital
camera during recording assessed the position of the brain
slices on the electrode field and the location of the laser
for stimulation.
Striatal field post-synaptic currents (fPSC) were recorded in
the dorsal striatum in response to stimulation of cortical afferents.
One MEA electrode located at 2.4–2.1 mm lateral to bregma, 0.8–
0.6 mm anterior to bregma, and 2.2–2.3 mm depth from brain
surface was set as stimulation one (Figure 5A), and fPSC were
evoked by single monopolar biphasic pulses (negative/positive,
100 µs per phase). For input/output curves, corticostriatal fibers
were stimulated with trains of three identical pulses at increasing
currents (250–3000 µV). The pulse amplitude of subsequent
stimuli was set to evoke 40% of the saturating fPSC. LTD
was induced by theta-burst stimulation (TBS) consisting of 10
trains spaced 15 s apart. Each train consisted of 10 bursts at
10.5 Hz (theta), and each burst consisted of four stimuli at
50 Hz (Figure 5B). Thus, the whole TBS stimulation period
lasted 2.5 min (Hawes et al., 2013). To determine the effects
of microglial activity in striatal fPSC evoked by stimulation
of cortical afferents, slices were incubated with either 100 µM
minocycline (Mino) (Sigma-Aldrich) (Song et al., 2015; Acharjee
et al., 2018) or 2 nM FKN (PeproTech, London, United Kingdom)
(Bertollini et al., 2006; Liu et al., 2015; Pandur et al., 2019) from
30 min prior to and during electrophysiological recordings.
Statistical Analysis
Data are presented as mean ± standard error of the mean
(SEM). Homogeneity of variance was checked using Levene’s
test. Analyses were performed by the unpaired Student’s t-test,
analysis of variance (ANOVA), or repeated measures two-way
ANOVA. Variance main components were analyzed with either
genotype and age, or genotype and treatment as factors by the
Bonferroni post hoc test. Values of p < 0.05 were considered
significant. Analyses were performed with the SPSS Statistics v25
(IBM Corp., United States) statistical package.
RESULTS
HD Induces an Early Decrease in Striatal
Fractalkine Levels
Since microglia have been proposed to contribute to the HD
pathological process, and the FKN-CX3CR1 axis has a central
role in controlling microglial activity, we first analyzed the
effects of mHtt on CX3CR1 and FKN expression in the striatum
of R6/1 mice at different ages (1, 8, 12, 20, and 30 weeks
of age). After mRNA quantification by qRT-PCR, we found
no CX3CR1 expression changes in the striatum of R6/1 mice
when compared with WT animals at any of the ages studied
(Figure 1A). However, we observed a significant 66% reduction
in FKN expression in the striatum of R6/1 mice at 8 weeks,
before disease symptoms arise, compared with WT (t = 18.74;
p < 0.0001). We found a similar FKN mRNA decrease in R6/1
mice at 12, 20, and 30 weeks (t = 3.26, p = 0.010; t = 15.66,
p < 0.0001; t = 13.45, p = 0.0009, respectively) (Figure 1B).
When we compared FKN protein levels between WT and R6/1
mice, we observed a significant decrease in the striatal FKN
concentration of R6/1 mice at 6, 8, 12, and 20 weeks (t = 2.599;
p = 0.038; t = 5.108, p = 0.0002; t = 3.195, p = 0.016; and
t = 2.700, p = 0.036, respectively) but not at 30 weeks of age
(Figure 1C). Similarly we observed a significant 44% reduction in
FKN expression in the cortex of R6/1 mice at 20 weeks (t = 5.299,
p = 0.0018), whereas the CX3CR1 gene expression remained
unvaried (Supplementary Figure 1).
We next assessed whether these FKN changes in R6/1
mice were also present in the putamen of HD patients and
in striatal neurons derived from cultured HD hiPSCs. We
found a significant reduction in FKN gene expression in the
putamen of HD patients with respect to controls (t = 2.792,
p = 0.0068) by qRT-PCR (Figure 2A). This reduction was also
found when we measured the striatal protein concentration of
FKN by western blot (Figure 2B). Cells derived in vitro from
hiPSCs showed differences in FKN gene expression depending
on the stage of differentiation (F(1,8) = 165, p < 0.0001).
We found low FKN expression in cells at neuroblast stage
(DIV 16), whereas mature striatal neurons (DIV 37) presented
high FKN gene expression (Figure 2C). This increase in
FKN gene expression was smaller in mature neurons derived
from HD hiPSCs (F(1,8) = 122.3, p < 0.0001) relative to
controls (Figure 2C). Immunocytochemical staining performed
in cultured hiPSCs at DIV 37 showed intense FKN staining
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FIGURE 1 | Fractalkine levels are decreased in the striatum of R6/1 mice. Histograms show the mHtt-induced fold change of CX3CR1 (A) and FKN (B) expression
quantified by qRT-PCR in the striatum of R6/1 male mice relative to WT littermates (1-week WT n = 3, 8-week WT n = 5, 12-week WT n = 8, 20-week WT n = 6,
30-week WT n = 4; 1-week R6/1 n = 7, 8-week R6/1 n = 5, 12-week R6/1 n = 10, 20-week R6/1 n = 6, 30-week R6/1 n = 4) (C) Quantification (left) and
representative immunoblots of striatal lysates (right) of FKN levels at different ages of R6/1 mice and their corresponding WT littermates. β-actin was used as loading
control. Data are expressed as a percentage of WT mice. (n = 3 mice/group, except the 8-week R6/1 group with n = 5). Two-tailed unpaired t-test; *p < 0.05;
**p < 0.01.
in neurites of mature neurons derived from control hiPSCs
(Figure 2D). A reduction in FKN immunostaining was observed
in neurites of neurons derived from the HD patient, when
compared with controls (t = 2.188, p = 0.047; Figure 2D).
These results indicate that asymmetric changes in the FKN-
CX3CR1 axis occur during striatal HD pathogenesis, specifically
modifying FKN levels.
R6/1 Microglia Exhibit a
Non-inflammatory Morphology
The asymmetric changes found in FKN signaling pointed to
modifications in microglial activity, since microglia are the only
cells in the brain parenchyma that express the FKN receptor
CX3CR1 (Nishiyori et al., 1998). Therefore, FKN decrease in
the striatum of R6/1 mice could potentially affect microglial
behavior in this HD model. We first analyzed changes in
microglial proliferation and morphology associated with classic
inflammatory activation in pre-symptomatic mice (12 weeks
of age) and symptomatic mice presenting motor symptoms
(20 weeks of age). We found no genotype-induced changes in
the number of Iba-1 immunostained microglia (Figures 3A,B).
To visualize any broad morphological changes in microglia
potentially indicative of a classical inflammatory response, we
performed a detailed analysis with 3DMorph (Figure 3D),
a sensitive program that allows analyzing many different
morphological parameters (York et al., 2018). In all cases, we
observed a surveillant ramified microglial shape (Figure 3C). We
found no effects of phenotype or age in either the microglial
cell volume, the territory occupied by the cells, the microglial
cell complexity, the number and length of cell processes, or the
number of endpoints (Figure 3D).
Increased Microglial Engulfment of
PSD-95-Positive Puncta in R6/1 Mice
In spite of the absence of microglial morphological changes,
FKN decrease in the striatum of R6/1 mice could potentially
be affecting the non-inflammatory activity of microglia. Since
FKN has been proposed to play an important role in regulating
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FIGURE 2 | Fractalkine expression is decreased in human HD striatum and hiPSC-derived striatal neurons. (A) HD-induced changes of FKN expression quantified
by qRT-PCR in human putamen relative to controls (HD cases n = 6; controls n = 11) (B) Quantification and representative immunoblots of FKN levels in human
putamen. β-actin was used as loading control (*p = 0.035, Student t-test; n = 6 cases/group). (C) HD-induced changes of FKN expression quantified by qRT-PCR in
HD60 iPSC-derived neuroblasts (DIV 16) and neurons (DIV 37) relative to Ctrl33 controls. 1CT values are relative to housekeeping gene values (n = 3
cultures/group). *p < 0.05, two-tailed unpaired t-test; **p < 0.01, Bonferroni post-hoc test. (D) Confocal photomicrographs of FKN immunostaining (green) in
cultured neurons (MAP2-positive; red) derived from Ctrl33 and HD60 iPSCs. Cellular nuclei are stained with Dapi (blue). Analysis of green channel picture (488 nm,
black and white image, FKN) and quantification of FKN-staining intensity relative to the MAP2-stained area denotes widespread FKN staining in Ctrl33 cells, which is
decreased in neurites of HD60 cells. *p < 0.05, two-tailed unpaired t-test (n = 3 cultures/condition). Scale bar: 14 µm.
microglia-mediated synaptic pruning (Gunner et al., 2019)
we estimated the density of PSD-95 immunopositive puncta
in the dorsal striatum of pre-symptomatic mice (12 weeks
of age) and symptomatic (20 week of age) R6/1 mice
(Figure 4A). Density of PSD-95 immunopositive puncta was
decreased by 71% in the dorsal striatum of R6/1 mice at
20 weeks of age (t = 4.205; p = 0.003) relative to WT,
whereas the 31% reduction found at 12 weeks of age did
not reach significance (t = 1.788; p = 0.107) (Figure 4A).
To estimate the microglial contribution to this decrease
we quantified the number of PSD-95 puncta engulfed by
microglia at 12 weeks of age using a synaptic engulfment
assay (Supplementary Video and Figures 4B,C). We found a
27% increase in the number of PSD-95 positive puncta inside
Iba1-stained microglia in the dorsal striatum of R6/1 mice
relative to WT (t = 3.051; p = 0.015). However, we found no
expression changes of microglial genes involved in phagocytosis
and trophic microglial activities in the striatum of 20-week-
old R6/1 mice compared with WT (Supplementary Figure 2).
These results point toward an abnormal increase in microglial
synaptic engulfment in pre-symptomatic HD animals that
could contribute to the progressive loss of synapses and
striatal dysfunction.
Microglial Activity Is Essential for
Corticostriatal Synaptic Long-Term
Depression
We next explored whether microglial activity has a role in
corticostriatal synaptic plasticity such as LTD induction, which
is known to be altered in HD mice (Creus-Muncunill et al.,
2019). We recorded fPSC in the dorsal striatum after electrical
stimulation of cortical afferents in sagittal slices (Figure 5A).
In all recordings we selected a stimulus pulse to evoke the
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FIGURE 3 | Lack of inflammatory morphology of microglia in 12-week-old R6/1 mice. (A) Illustrative Iba-1 immunostaining images of the striatum from WT and
pre-symptomatic R6/1 mice (12 weeks of age). Scale bar: 40 µm. (B) Quantitative analysis of the number of Iba-1 positive cells per section. Data are expressed as a
percentage of WT values (WT n = 3 female + 5 male mice, R6/1 n = 3 female + 3 male mice). (C) Illustrative images of 3DMorph analysis of individual microglial cells
isolated from confocal microphotographs. From each full cell volume, 3D skeletons were generated and then processed to obtain an image of either major branches
or branch end points. In skeleton figures, colors indicate order of connectivity (red = primary, yellow = secondary, green = tertiary, and blue = connected to end
point). (D) Quantitative analysis of the microglial cell volume, territory occupied by each cell, microglial cell complexity (cell territory/cell volume), number and
longitude of cell processes, and number of endpoints. (WT n = 3 female + 4 male, R6/1 n = 3 female + 3 male mice).
40% of the saturating fPSC in an input/output curve. In these
conditions, the amplitude of evoked fPSC in the striatum of
R6/1 mice decreased 54% compared with WT (F(1,18) = 4.52,
p = 0.0048), whereas the presence of either 100 µM Mino or
2 nM FKN in the bath did not modify basal fPSC amplitude
(Figures 5C,D). To evaluate synaptic dysfunction, we induced
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FIGURE 4 | Microglia increases PSD-95-positive puncta engulfment in 12-week-old R6/1 mice. (A) Illustrative confocal images of PSD-95 immunostaining and
quantitative analysis of the number of PSD-95-positive puncta per section in the striatum of WT and R6/1 mice of 12 and 20 weeks of age. Graph data are
expressed as a percentage of WT values. (B) Illustrative confocal images of Iba-1 (green) and PSD-95 (red) double immunostaining in the striatum of WT and R6/1
mice at 12 weeks of age. (C) Three-dimensional microglia reconstruction and surface rendering by means of Imaris software showing larger relative numbers of
PSD-95 positive puncta inside Iba-1 positive cells in R6/1 mice. Data are expressed as a percentage of engulfed puncta in WT striatum. *p = 0.0158; **p = 0.003,
two-tailed unpaired t-test (n = 2 female + 3 male mice/group). Scale bar: 15 µm in a and b; 7 µm in c.
LTD using a TBS protocol (Figure 5B) and compared the
amplitude of evoked striatal fPSC. We analyzed the effect of
microglial activity depletion over LTD by adding 100 µM Mino
in the bath (Figures 5C–E). After two-way ANOVA analysis,
we found fPSC amplitude differences among the four mouse
groups (WT-Ctrl, WT-Mino, R6/1-Ctrl, and R6/1-Mino) 30 min
after LTD induction (F(3,20) = 13.88, p < 0.0001). Factor
analysis showed genotype (F(1,20) = 27.62, p < 0.0001) and drug
(F(1,20) = 5.838, p = 0.028) effects, and genotype/drug interactions
(F(1,20) = 13.174, p = 0.002). According to the Bonferroni
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FIGURE 5 | Microglia are essential for long-term depression and fractalkine restores corticostriatal synaptic plasticity in 12-week-old R6/1 mice. (A) Drawing of a
mouse brain sagittal section showing the location of stimulating and recording electrodes for corticostriatal fPSC recordings (adapted from Paxinos Mouse Brain
Atlas). (B) Schematic of the TBS paradigm for LTD induction. A single train of stimuli is illustrated in brackets and annotated to show the stimuli number and
frequency, as well as the time scale. (C) Representative fPSC traces prior to TBS (pre-TBS, black) and after TBS (post-TBS, blue) in the six conditions of
electrophysiological recordings. (D) Histograms show the quantification of fPSC amplitude in the striatum of WT and R6/1 mice relative to WT (n = 10 male
mice/group), and in the presence of either 100 µM minocycline (Mino; n = 5 male mice/group) in the bath or 2 nM fractalkine (FKN; n = 5 male mice/group) in the
bath, relative to absence in the bath (Ctrl). fPSC amplitude was calculated as the mean of 30 different fPSC evoked every 30 s during 15 min prior to TBS.
One-factor ANOVA test; *p < 0.05 different from WT (E,F) Graphs show the time course and quantification of fPSC evoked at corticostriatal synapses and the LTD
induced after a TBS (arrow) in presence or absence of either (E) 100 µM Mino in the bath (n = 5 male mice/group) or (F) 2 nM FKN in the bath (n = 5 male
mice/group). fPSC amplitudes are represented as a percentage of baseline. Histograms show the mean amplitude of fPSC evoked at 29–30 min after TBS.
Bonferroni’s Multiple Comparison post hoc test; *p < 0.05, **p < 0.01, different from WT-Ctrl; #p < 0.05 different from R6/1-Ctrl.
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post-hoc test, TBS induced a decrease in the fPSC amplitude only
in WT-Ctrl mice (Figure 5E), while LTD was not induced in
WT-Mino nor R6/1-Ctrl and R6/1-Mino groups. These results
suggest that microglial activity is essential for corticostriatal
synaptic plasticity.
Fractalkine Restores Corticostriatal
Long-Term Depression in R6/1 Mice
We then evaluated the putative role of FKN in corticostriatal
LTD dysfunction in R6/1 mice by adding 2 nM FKN in the
bath (Figures 5C,D,F). In these conditions, we found fPSC
amplitude differences among the four mouse groups (WT-
Ctrl, WT-FKN, R6/1-Ctrl, and R6/1-FKN) 30 min after LTD
induction (two-way ANOVA, F(3,20) = 9.474, p = 0.001).
Factor analysis showed effects of genotype (F(1,20) = 19.330,
p = 0.0004) and treatment (F(1,20) = 5.581, p = 0.031), but
not genotype/treatment interaction (F(1,20) = 3.512, p = 0.0792).
According to the Bonferroni post hoc test, TBS decreased
the fPSC amplitude in WT-Ctrl, WT-FKN, and in R6/1-
FKN mice, although the magnitude of the induced LTD in
these animals was smaller than the one observed in WT
mice (Figure 5F). These results indicate that a lack of FKN
is involved in striatal synaptic plasticity dysfunction in pre-
symptomatic R6/1 mice.
DISCUSSION
Microglia have long been regarded as a mere driver of chronic
inflammation in neurodegenerative diseases. With the present
work, we make a meaningful contribution to the growing
appreciation that their role is much more nuanced. In our
HD mouse model, we found no gross, inflammatory microglial
morphological changes. Instead, 3D reconstruction allowed us
to visualize an increase in their engulfment of post-synaptic
material, potentially driven by changes in neuronal FKN. Our
data also highlight the role for microglia in altering the
electrophysiological characteristics of corticostriatal synapses,
specifically LTD, with FKN being central in modulating this
microglial homeostatic function.
FKN-CX3CR1 signaling depletion is often correlated with
increased neuroinflammation (Bachstetter et al., 2011). In
response to pathogenic stimuli microglia acquire a pro-
inflammatory profile and decrease CX3CR1 expression or
activity (Ransohoff and Perry, 2009). Similarly, CX3CR1
polymorphisms that decrease receptor activity or affinity for
FKN are linked to enhanced disease progression in amyotrophic
lateral sclerosis (Lopez-Lopez et al., 2014; Calvo et al.,
2018), Alzheimer’s disease (Finneran and Nash, 2019) and
neuroinflammatory pathologies (Arli et al., 2013; Cardona
et al., 2018). More interestingly, knocking out CX3CR1 in
Alzheimer’s disease mice showed reduced Aβ deposition and
increased microglial phagocytic activity (Liu et al., 2010).
Also, a recent article showed that lowering CX3CR1 levels
or partially inhibiting its activity in the brain might be
a therapeutic strategy to increase neuronal Aβ clearance,
reduce Aβ levels and delay progression of Alzheimer’s disease
(Hickman et al., 2019). These studies suggest that a decrease
in microglia-neuron communication, caused by a reduction
of FKN-CX3CR1 signaling, is sufficient for losing the anti-
inflammatory and homeostatic function of microglia, likely also
affecting physiological processes (Chamera et al., 2019).
Interestingly, we found no significant changes in CX3CR1
expression in R6/1 mice over time, but instead a significant drop
in FKN expression. These results are consistent with two previous
gene expression analyses showing an mHtt-induced decrease in
FKN expression in STHdhQ111/Q111 cells (Lee et al., 2007) and
the striatum of 12-week-old R6/2 mice (Vashishtha et al., 2013).
Additionally, in our study the FKN decrease preceded the onset
of symptoms, with no inflammatory microglial morphological
changes. Furthermore we observed no expression changes in any
of the microglial genes analyzed in the striatum of 20-week-
old, symptomatic R6/1 mice. Based on these data, pathological
changes in the FKN-CX3CR1 axis could instead be driven by
mHtt-induced changes in neuronal FKN production, rather
than by microglial deregulation. This result is confirmed by
other studies showing a lack of inflammatory markers in the
striatum of non-symptomatic R6/1 mice (Pérez-Severiano et al.,
2002; Renoir et al., 2015). In this line, a systems biology
analysis of different HD mouse models reported wide mHtt-
induced gene expression deregulation in the striatum in a
CAG-length dependent manner (Veldman and Yang, 2018).
In this study the main group of deregulated proteins was
involved in synaptic processes and included decreased FKN
expression. Furthermore, network analysis of human post-
mortem expression microarrays revealed FKN as an important
novel factor in HD pathogenesis and survival (Chandrasekaran
and Bonchev, 2016). Further detailed studies might characterize
the molecular pathways involved in the mHtt-induced FKN
down-regulation.
Fractalkine has been proposed to act in the adult brain as
a neuronal signal maintaining microglia in a surveillant state
(Ransohoff and Perry, 2009). Conversely, other studies reported
decreased release of inflammatory factors and attenuated
microglial activation in the striatum of both CX3CR1-knockout
(KO) and knockdown mice after experimental ischemia (Tang
et al., 2014; Liu et al., 2015) and in CX3CR1-KO mixed
cultures (Mattison et al., 2013). Furthermore, decreased FKN
gene expression was also observed in aged BACHD mice
lacking metabotropic glutamate receptor 5, which was proposed
to account for decreasing microglial activation in these mice
(Carvalho et al., 2019). These studies suggest instead a role for
FKN in the pro-inflammatory signaling of activated microglia
different to that of surveillant microglia.
Our results suggest that decreased FKN may be modifying
the role that microglia play in synaptic plasticity. Moreover,
it has been proposed that FKN could play an important
role in regulating synapse engulfment by microglia (Gunner
et al., 2019). Previous studies demonstrated a reduction of
MSN spine density in the striatum of 3-month-old YAC128
mice (Marco et al., 2013) and in hippocampal apical dendrites
from R6/1 mice (Miguez et al., 2015). Also in R6/1 mice,
decreased PSD-95 levels, which may affect the strength
and number of synaptic contacts, have been proposed to
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be in the basis of the functional alterations observed in
HD (Nithianantharajah et al., 2008). Accordingly, PSD-95
levels are decreased in the striatum of symptomatic knock-
in HdhQ7/Q111 mice, and this correlates with a drop in
the number of PSD-95 immunopositive puncta and altered
corticostriatal long-term potentiation (Puigdellívol et al., 2015).
We here describe for the first time changes in engulfment of
PSD-95 immunopositive puncta by striatal microglia at pre-
symptomatic stages of HD, which could contribute to the
progressive loss of synapses and striatal dysfunction. Increased
microglia-mediated engulfment of synaptic material has been
described in mouse models of Alzheimer’s disease (Hong
et al., 2016), schizophrenia (Sekar et al., 2016), and Rett
syndrome (Derecki et al., 2012) via expression of traditional
immune complement molecules (Hong et al., 2016; Sekar
et al., 2016). These findings suggest that excessive microglia-
mediated synaptic engulfment leads to synaptic dysfunction
and could constitute a common pathological mechanism
for many neurological and psychiatric pathologies. Whether
environmental enrichment increases PSD-95 levels and improves
cognition through improving microglia-neuron signaling in HD
should be further explored.
Early corticostriatal LTD dysfunction in HD has been widely
observed in R6/1 mice and other HD models (Cummings
et al., 2007; Creus-Muncunill et al., 2019; Ghiglieri et al.,
2019) and is considered one of the abnormal synaptic
mechanisms of the disease (Unschuld et al., 2012; Burgold
et al., 2019). We here found that depletion of microglial
activity with Mino induced a decrease in corticostriatal LTD
in WT mice, suggesting that microglial activity is essential for
striatal synaptic function. Similar results in mouse hippocampus
also suggest a role for microglia in modulating synaptic
plasticity. For example, Mino has been reported to prevent
the impairment of hippocampal long-term potentiation in a
mouse model of Alzheimer’s disease (Wang et al., 2004) and in
experimental sepsis-associated encephalopathy (Hoshino et al.,
2017). Interestingly, depletion of microglial activity has also
been associated with reduced synaptic pruning in the basolateral
amygdala of an experimental autoimmune encephalomyelitis
mouse model of multiple sclerosis (Acharjee et al., 2018). In
this line, FKN-induced partial restoration of LTD in R6/1 is
also a new finding, further strengthening a role for impaired
neuron-microglia communication in the early striatal synaptic
dysfunction characteristic of HD.
The specific mechanism linking microglial homeostatic
activity with this LTD impairment is still to be determined,
but a role of FKN in synaptic plasticity has been previously
suggested, with controversial results. CX3CR1-deficient mice
show impaired synapse development during the early post-
natal period (Hoshiko et al., 2012), which is associated with
weak synaptic transmission and impaired functional connectivity
(Zhan et al., 2014). In this line, juvenile CX3CR1-KO mice
showed increased hippocampal LTD when compared with WT,
but no modifications in the adult hippocampus (Paolicelli
et al., 2011). Accordingly, clinical and experimental studies
suggest that mHtt-induced aberrant development is at the
root of some HD functional alterations (Molero et al., 2016;
Hd iPSC Consortium, 2017; Van der Plas et al., 2019), in
particular cortical neurons are hyperexcitable and display
dysmorphic processes (Cepeda et al., 2019). Alterations in
the FKN-CX3CR1 axis could contribute to this pathological
development, as this signaling system is critical for functional
maturation of synapses (Hoshiko et al., 2012). Conversely,
disruption of FKN-CX3CR1 signaling in adult WT mice results
in hippocampal long-term potentiation impairment leading to
a loss of synaptic plasticity and cognitive dysfunction (Rogers
et al., 2011). This loss of hippocampal synaptic plasticity was
accompanied by an increase of IL-1β expression and p38
phosphorylation (Rogers et al., 2011). Interestingly, a significant
increase in phosphorylated p38 levels has also been described in
the striatum of 20-week-old R6/1 mice (Saavedra et al., 2011).
Thus, further studies might provide evidence on a putative
mechanistic link between FKN, phosphorylated p38, IL-1β
release and the loss of striatal synaptic plasticity from post-natal
development and adulthood to the onset of symptoms in HD.
Another mechanism of canonical neuron-microglia
communication involves the CD200-CD200R1 axis. As
described for FKN, CD200 is expressed by neurons and
interacts with its specific receptor CD200R1, mostly expressed
by microglia in the brain (Shrivastava et al., 2012). Recent
work reported increased neuronal CD200 gene expression
and protein levels in the brain parenchyma, along with HD
pathogenesis in R6/1 mice, but no changes in microglial
CD200R1 (Comella-Bolla et al., 2019). This study suggests that
neuron-microglia communication through CD200-CD200R1
interaction is not compromised, and CD200 up-regulation
could represent a neurotrophic signal to sustain neuronal
function in the latest stages of HD (Comella-Bolla et al.,
2019). Conversely, the altered FKN-CX3CR1 axis emerges
as a specific pathological mechanism in neuron-microglia
communication in HD, leading to the impairment of microglial
homeostatic activity.
Taken together, our results reveal a key role for FKN in
the pathophysiology of HD. FKN-CX3CR1 signaling deficits in
HD lead to abnormal neuron-microglia interactions, which may
contribute to the early striatal synaptic plasticity dysfunction
characteristic of this neurological disease. However, further
functional analysis might elucidate the critical contribution
of microglial phagocytic activity to the pathological synaptic
loss in the striatum. Similarly, many key aspects about the
role of the FKN-CX3CR1 axis in microglia-mediated synaptic
pruning and plasticity during neurodegeneration remain to be
clarified. Learning more about the intricate roles that microglia
play outside of their classic inflammatory response to damage
could give us more insight into HD pathophysiology, allowing
for the exploration of new therapeutic approaches for this
neurological disorder.
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